Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses —————— — Research & development —————— — Operating income -39.6 K-236.92 K-151.15 K-291.27 K-2.52 M-723.23 K -3.69 M Non-Operating Income, Total 03.18 M-1.05 M4.52 M2.05 M2.08 M 7.59 M Interest expense, net of interest capitalized —————— — Non-Operating Income, excl. Interest Expenses 03.18 M-1.05 M4.52 M2.05 M2.08 M 7.59 M Unusual income/expense —————— — Pretax income -39.6 K2.94 M-1.2 M4.23 M-472.48 K1.35 M 3.91 M Equity in earnings —————— — Taxes —————— — Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations -39.6 K2.94 M-1.2 M4.23 M-472.48 K1.35 M 3.91 M Discontinued operations —————— — Net income -39.6 K2.94 M-1.2 M4.23 M-472.48 K1.35 M 3.91 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders -39.6 K2.94 M1.2 M1.83 M-472.48 K1.35 M 3.91 M Basic earnings per share (Basic EPS) 0.070.13-0.04-0.44-0.040.1 -0.22 Diluted earnings per share (Diluted EPS) 0.070.13-0.04-0.41-0.040.1 -0.19 Average basic shares outstanding 6.67 M7.4 M11.65 M22.71 M30 M30 M — Diluted shares outstanding 6.67 M7.4 M11.65 M22.76 M30 M30 M — EBITDA —————— — EBIT —————— — Cost of revenue —————— — Other cost of goods sold —————— — Depreciation & amortization (cash flow) —————— —